1nhaler Ltd
eDR22Effective DR: 22/100. Bottom 25%. Measured by StartupHub.ai. Median 68.Agent49Agent Readiness: 49/100. Top 25%. Measured by StartupHub.ai. Median 41.Developer of a novel pop-up cardboard dry powder inhaler platform for sustainable and accessible drug delivery.
About
1nhaler is a Scotland-based medical technology company that develops a patented, single-dose dry powder inhaler platform made predominantly from FSC-certified cardboard. Designed to be ultra-portable, easy to use, low cost, and low carbon, the propellant-free device delivers dry powder formulations for conditions such as asthma, allergies, epilepsy, and Parkinson's. The company serves pharmaceutical partners, prescribers, and patients by offering an eco-friendly, accessible alternative to traditional plastic inhalers for rescue medications, clinical trials, and potential vaccine administration.
Similar companies
Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Shares Biotechnology, Medical Devices
Developing gene editing therapies to lower cholesterol.
Shares Biotechnology, Drug Delivery
AI-powered breast cancer detection and risk assessment solutions.
Shares HealthTech, Medical Devices
Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
Shares Biotechnology, HealthTech
Pioneering vision restoration therapies for severe retinal degenerations.
Shares Biotechnology, Healthcare
Developing ultrasound-mediated nonviral genetic medicines.
Shares Biotechnology, Healthcare
“SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery…” r/Hemophilia
Key facts
- Website
- 1nhaler.com
- Headquarters
- Edinburgh, United Kingdom
- Founded
- 2017
- Total funding
- $5M (Follow-on)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 3 Nov 2026 | Follow-on | $3M | Archangel Ventures |
| 17 Nov 2025 | Seed | $2M | Archangel Ventures |
Tech stack
Detected on 1nhaler.com, last scanned 3 Nov 2026. Run your own scan
- CMS / Builders
- Squarespace
- Email provider
- Microsoft 365
1nhaler Ltd scores 10. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is 1nhaler Ltd trustworthy and reputable?
StartupHub's Data Trust & Reputation score for 1nhaler Ltd is 70 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has 1nhaler Ltd raised?
1nhaler Ltd has raised a total of $5M in funding. The most recent round on record is Follow-on.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for 1nhaler Ltd
